Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TRANS GENIC to fully acquire subsidiaries through stock swap

Thursday, 15 May 2014 04:30am EDT 

TRANS GENIC INC:To fully acquire 68.7 pct-owned subsidiary GeneticLab Co., Ltd. and 88.5 pct-owned subsidiary Primmune Inc. through stock swap, effective Aug. 1.One share of GeneticLab will be exchanged for 7.2 shares of the company, and one share of Primmune will be exchanged for 38.3 shares of the company. 

Company Quote

17.0 +4.23%
26 Dec 2014